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Abstract
Background: Genetic and environmental risk factors contribute to periodontal disease, but the underlying
susceptibility pathways are not fully understood. Epigenetic mechanisms are malleable regulators of gene function
that can change in response to genetic and environmental stimuli, thereby providing a potential mechanism for
mediating risk effects in periodontitis. The aim of this study is to identify epigenetic changes across tissues that are
associated with periodontal disease.
Methods: Self-reported gingival bleeding and history of gum disease, or tooth mobility, were used as indicators of
periodontal disease. DNA methylation profiles were generated using the Infinium HumanMethylation450 BeadChip
in whole blood, buccal, and adipose tissue samples from predominantly older female twins (mean age 58) from the
TwinsUK cohort. Epigenome-wide association scans (EWAS) of gingival bleeding and tooth mobility were
conducted in whole blood in 528 and 492 twins, respectively. Subsequently, targeted candidate gene analysis at 28
genomic regions was carried out testing for phenotype-methylation associations in 41 (tooth mobility) and 43
(gingival bleeding) buccal, and 501 (tooth mobility) and 556 (gingival bleeding) adipose DNA samples.
Results: Epigenome-wide analyses in blood identified one CpG-site (cg21245277 in ZNF804A) associated with
gingival bleeding (FDR = 0.03, nominal p value = 7.17e−8) and 58 sites associated with tooth mobility (FDR < 0.05)
with the top signals in IQCE and XKR6. Epigenetic variation at 28 candidate regions (247 CpG-sites) for chronic
periodontitis showed an enrichment for association with periodontal traits, and signals in eight genes (VDR, IL6ST,
TMCO6, IL1RN, CD44, IL1B, WHAMM, and CXCL1) were significant in both traits. The methylation-phenotype
association signals validated in buccal samples, and a subset (25%) also validated in adipose tissue.
Conclusions: Epigenome-wide analyses in adult female twins identified specific DNA methylation changes linked
to self-reported periodontal disease. Future work will explore the environmental basis and functional impact of
these results to infer potential for strategic personalized treatments and prevention of chronic periodontitis.
Keywords: Epigenetics, Periodontitis, DNA methylation, Gene expression, Metabolomics, Epigenome-wide
association scan (EWAS)
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Background
Periodontal disease is a chronic inflammatory disease that
poses a significant burden among older populations. The
disease causes inflammation and bleeding of the gingival
tissues as a result of the accumulation of microbial dental
plaque, and in its destructive form, periodontitis results in
progressive destruction of the supporting structures of the
teeth leading to looseness of the teeth and ultimately tooth
loss. The etiology of the disease involves interplay between
both intrinsic and extrinsic factors such as genetic suscep-
tibility, diet, oral hygiene, and inflammatory response to
exposure to complex pathogens. An increasing number of
genome-wide association studies [1, 2] and candidate gene
reports [3–5] have explored genetic susceptibility to peri-
odontal disease. Genes that harbor genetic variants ro-
bustly associated with the development of periodontal
disease are related to inflammatory response and alveolar
bone resorption; however, their mechanistic pathways are
not clearly understood.
Epigenetic modifications, including DNA methylation, are
key regulators of gene function. Epigenetic marks can
change in response to genetic and environmental stimuli,
thereby providing a mechanism for the interaction of gen-
etic and environmental effects in the context of disease sus-
ceptibility. A number of epigenetic changes have been
identified to contribute towards and act as biomarkers of
human diseases, including cancers, inflammatory and
neurological disorders, and mental health traits [6, 7]. How-
ever, only a few studies so far have explored epigenetics in
periodontal disease, although periodontal disease is charac-
terized by an inflammatory response. The majority of epi-
genetic research into periodontal disease to date has
focused on candidate genes in case-control samples [8–10].
Previous studies predominantly explored the hypothesis
that epigenetic regulation mediates gingival inflammation in
epithelial tissue by changing the function of cytokine genes.
This includes specifically the upregulation of proinflamma-
tory cytokines and other signaling molecules and downreg-
ulation of anti-inflammatory cytokines to activate a full
inflammatory response.
Although both genetic and environmental risk factors
contribute to periodontal disease susceptibility, the
underlying molecular pathways of these risk effects are
not fully understood. Epigenetic studies may uncover
mechanisms mediating genetic and environmental risk
effects on periodontitis, which will help towards devel-
oping strategic personalized treatments and prevention.
The aim of the current study was to investigate
epigenomic variation associated with chronic periodon-
tal disease using a twofold approach. The first stage
explored the association of periodontal traits with
epigenome-wide variation in over 500 female adult
twins. Thereafter, a candidate gene approach was under-
taken, where we explored multi-omics signatures at
candidate genomic regions previously implicated in peri-
odontitis [1, 2, 11–13]. The association between peri-
odontal status and DNA methylation levels was assessed
in whole blood, as the most widely used sample type; in
adipose tissue, as an independent sample type; and in
buccal tissue, as a representative biological sample from
the oral cavity.
Materials and methods
Study population
Study participants were older female twins (mean age =
58 years old; age range 19–82 years old; 83% are mono-
zygotic (MZ) and 10% are dizygotic (DZ)) who were en-
listed in the TwinsUK registry [14]. The TwinsUK
registry is one of the largest adult twin cohorts encom-
passing a wide range of phenotypes, and biological sam-
ples and data. Informed consent was obtained from all
participants before sample and data collection. Zygosity
was determined by standard questionnaire [15] and con-
firmed by DNA short-tandem repeat fingerprinting. The
number of samples across different datasets explored in
this study is described in Table 1. Gingival bleeding sta-
tus was obtained from 528 female individuals (mean age
57.9, age range 18.6–80.9, mean BMI 26.9, BMI range
16.1–49.3), and tooth mobility data was obtained from
492 female individuals (mean age 58.0, age range 18.6–
80.9, mean BMI 26.9, BMI range 16.2–52.7), for whom
blood DNA methylation profiles were also available. The
date of the clinical visit for periodontal data collection
was within 5 years of the blood DNA extraction date.
Buccal tissue DNA methylation samples included 43 fe-
male individuals (mean age 57, age range 34–73; subjects
including 20 MZ individuals, 16 DZ individuals, and 7
singletons) with gingival bleeding phenotype and 41 fe-
males (mean age 57, range 34–73, 20 MZ individuals, 12
DZ individuals, 9 singletons) with tooth mobility pheno-
type. Lastly, the adipose tissue DNA methylation sample
included 556 female individuals (mean age 59, range 39–
85, 39% MZ) with gingival bleeding phenotype and 501
female individuals (mean age 58, range 39–85, 39% MZ,
61% DZ) with tooth mobility phenotype.
Periodontal phenotypes
Periodontal phenotype data on tooth mobility and gin-
gival bleeding were collected by self-reported question-
naires during clinical visits. A single question was used
to determine gingival bleeding (question: “Have you ever
had the condition of gum bleeding”) and tooth mobility
(question: “Have you ever had the condition of gum
decay or loose teeth”). Participants were asked to answer
either “yes” or “no” to these questions. Therefore, both
phenotypes were binary variables. In the blood DNA
methylation dataset, 269 individuals out of 528 (51%)
were gingival bleeding positive and 121 out of 492 (25%)
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were tooth mobility positive. In the buccal methylation
dataset, 25 individuals out of 43 were gingival bleeding
positive and 12 individuals out of 41 were tooth mobility
positive. In the adipose DNA methylation dataset, 265
individuals out of 556 were gingival bleeding positive
and 102 individuals out of 501 were tooth mobility
positive.
Epigenome-wide profiling of DNA methylation
The Infinium HumanMethylation450 BeadChip Kit (Illu-
mina Inc., San Diego, CA, USA) was used to obtain the ra-
tio of array intensity signal from the methylated beads over
the sum of methylated and unmethylated bead signals plus
100. This array contains a combination of two types of
probes, Infinium I (28%) and Infinium II (72%) probes,
which use different detection methods. Infinium I probes
include two bead types, a methylated and an unmethylated,
while Infinium II probes are measured in one bead type
that requires extension of color-labeled dideoxynucleotides
to determine the methylation status. To correct for tech-
nical bias caused by the probe design in this platform, the
beta-mixture quantile normalization (BMIQ) method and
background correction were applied for each sample [16].
Subjects with more than 1% of missing values were consid-
ered as outliers and were removed from the analysis. Probes
with more than 1% of missing values among all samples
with detection P value > 0.05, probes located on Y chromo-
some, and probes that mapped incorrectly or that mapped
to multiple locations in the genome (with up to two mis-
matches) were removed. We also used the 65 designed sin-
gle nucleotide polymorphism (SNPs) to check for sample
swaps and included these probes in the analysis. In total,
after all exclusions, we analyzed 452,865 probes in blood,
436,814 probes in buccal tissue, and 467,928 probes in adi-
pose samples. The methylation beta levels at each probe
were quantile normalized to the standard normal distribu-
tion (N (0, 1)) before downstream epigenome-wide associ-
ation analysis. Epigenome-wide association scans aimed to
identify specific sites across the genome where epigenetic
levels significantly differed between periodontal disease-
positive and periodontal disease-negative group samples,
that is, identifying differentially methylated positions
(DMPs) for periodontal disease. CpG sites that surpassed
epigenome-wide significance did not overlap common
genetic variants (minor allele frequency > 5%) in the
UK10K project [17].
RNA-sequencing gene expression quantification in whole
blood
RNA-sequencing (RNASeq) data from peripheral whole
blood samples were available for 384 subjects and were gen-
erated, quantified, and normalized as previously described
[18, 19]. Briefly, RNASeq reads were aligned to the UCSC
(University of California Santa Cruz) Genome Browser
GRCh37 reference genome with the Burrows-Wheeler
Aligner [20], and genes annotated using GENCODE v.10.
Samples with fewer than 10 million reads mapping to
known exons were excluded. All read count quantifications
were carried out at the exon level and were corrected for
variation in sequencing depth between samples by normal-
izing the number of reads to the median number of
well-mapped reads. Exons expressed in fewer than 90% of
individuals were excluded. Rank-based inverse normal
transformation was then applied to the normalized read
counts prior to downstream analysis. The number of indi-
viduals included in the gene expression analysis with avail-
able gingival bleeding and with tooth mobility phenotypes
was 342 and 335, respectively.
Metabolomics data
Fasting whole blood samples were extracted and stored
at − 80 °C until they were processed by Metabolon, Inc.
(Durham, NC, USA) using a non-targeted mass spec-
trometry platform, as previously described [21]. After
profiling, normalization was performed to correct for
variation resulting from instrument inter-day tuning dif-
ferences. Briefly, each compound was normalized so that
the median of the run-day was equal to one (1.00) and
each data point was scaled proportionally. The analysis
only focused on 271 known metabolites, which included
amino acids, carbohydrates, vitamins, lipids, nucleotides,
small peptides, and xenobiotics. This metabolomics data
was available in 472 (tooth mobility) and 506 (gingival
bleeding) individuals for whom phenotype and whole
Table 1 Samples used in blood, buccal, and adipose tissue data analysis for two periodontal traits
Gingival bleeding a, b Tooth mobility Overlap between two periodontal traits
Blood
DNA methylation 528 492 474
RNAseq 342 (120) 335 (112) 333
Metabolomics 506 (506) 472 (472) 454
Buccal DNA methylation 43 41 40
Adipose DNA methylation 556 501 501
aUnits represent the number of individuals
bNumbers in brackets represent the number of individuals who also have DNA methylation data
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blood DNA methylation data were also profiled. The
overlap in datasets across the two periodontal traits,
DNA methylation, and blood gene expression and meta-
bolomics samples is shown in Table 1.
Candidate gene selection
We focused on 37 candidate genes for periodontitis
(Table 2). Some of these genes were selected as they were
previously identified through genome-wide association
studies (GWAS) of periodontitis, while other regions were
included because of their biological function and previous
research exploring their contribution to periodontal dis-
ease (see Table 2). Each candidate genomic region was de-
fined by the following criteria: for GWAS SNPs, the
region was set with a range of 10 kb around the lead SNP,
and for biological candidate genes, we included the gene
body and 5 kb either side of the gene boundary. In total,
28 of the 37 candidate genes were represented on the Infi-
nium HumanMethylation450 array and 247 CpG sites
passed quality control assessment in blood.
Further to the epigenome-wide analyses in whole
blood, we assessed the association between periodontal
traits and buccal tissue DNA methylation at the candi-
date CpG sites, as well as that for adipose tissue DNA
methylation. Buccal DNA methylation analyses were car-
ried out in 41 (tooth mobility) and 43 (gingival bleeding)
individuals at a subset of 248 CpG sites that passed qual-
ity control assessment in the buccal dataset.
Statistical analysis
We performed a linear mixed-effect regression (LMER)
model to assess the association between DNA methyla-
tion levels at each probe and periodontal status of the
individual. We initially tested a full linear regression
model where normalized DNA methylation levels were
the response variable and each periodontal phenotype
was a fixed effects predictor, along with a number of co-
variates. Covariates included fixed effects (age, Illumina
beadchip, Illumina beadchip position, BMI, smoking sta-
tus, blood cell composition (monocytes, natural killer
cells, granulocytes, CD8 T cells, and CD4 T cells), DNA
extraction year, and time difference between the time
point of dental phenotype collection and DNA extrac-
tion) and random effects (family structure and zygosity)
variables. Blood cell counts were estimated using the
DNA Methylation Age Calculator online [22]. The fit of
the full linear regression model was compared to the fit
of a null model, which excluded the dental phenotype as
a predictor variable. The association between DNA
methylation levels and periodontal traits were carried
out using lmer within R 3.4.3 in the package “lme4.” In
buccal samples, the association between periodontal sta-
tus and methylation levels was also assessed using LMER
adjusting for fixed effects (age and beadchip) and
random effects (zygosity and family structure) as in
blood. In adipose samples fixed effects included age,
beadchip, BMI, bisulfite conversion level, and bisulfite
efficiency, and random effects were as described in
blood. Multiple testing correction was carried out using
a false discovery rate (FDR) at 5% [23]. Similarly, we
tested if exon expression levels were differentially associ-
ated with periodontal traits using a linear mixed-effects
regression model. The analysis was conducted for each
exon adjusting for fixed effects (age, age squared, smok-
ing and GC mean, insert size mode) and random effects
(family structure, zygosity, date, and primer index).
Heritability estimation was conducted using a classical
twin study model. The phenotypic variance is partitioned
into three latent components: additive genetic, shared en-
vironmental, and unique environmental factors. In this
context, shared environmental factors typically represent
familial exposures shared by both twins (for example, in
childhood), whereas unique environmental factors are
exposures that are specific to each individual subject.
Structural equation modeling was used to estimate the
best-fitting model for the traits using the likelihood ratio
test [24]. The contribution of each latent component to
the phenotypic variance was also quantified. We calcu-
lated heritability in R with the “mets” package.
Results
ZNF804A methylation associates with gingival bleeding
Epigenome-wide analysis of gingival bleeding was carried
out in the blood methylome across 452,865 probes in
528 subjects (Table 1). We identified one CpG site sig-
nificantly associated with gingival bleeding (cg21245277;
beta = − 0.33, p value = 7.17e−8, FDR = 0.03; Table 3,
Additional file 1: Table S1). This CpG site is located
within the 5′ UTR of a protein-coding gene, ZNF804A
(Fig. 1a). Polymorphisms of this gene confer increased
susceptibility to mental health disorders such as schizo-
phrenia and bipolar disorders and contribute to heroin
addiction [25]. CpG site cg21245277 was significantly
hypo-methylated in participants who experienced gin-
gival bleeding (Fig. 1b).
To assess if genetic or environmental factors influence
blood DNA methylation levels at this site, we carried out
heritability analysis using the classical twin model. We
established a moderate impact of genetic variation on
DNA methylation variability at this CpG site (heritability
of 23%), while the majority (77%) of methylation vari-
ance was attributed to environmental factors unique to
each individual.
To explore the potential functional role of the methyla-
tion signal in ZNF804A, we carried out additional omic
analyses. First, RNA-sequencing gene expression data in
342 twins identified two exons in ZNF804A, which are
expressed in blood. One exon showed a nominally
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Table 2 Chronic periodontitis GWAS loci and candidate genes from previous studies
Gene symbola 450 K probes b SNPs Functional association with periodontitis or other diseases References
NIN 2 rs12883458 Genome-wide significant association with severe chronic periodontitis Rhodin et al.
[1]
ABHD12B 2 rs12883458
WHAMM 9 rs2890313
KCNK1 0 rs11800854 Genome-wide significant association with red complex high colonization
DAB2IP 0 rs10760187 Genome-wide significant association with Porphyromonas gingivalis high colonization
CLEC19A 1 rs1156327 Genome-wide significant association with PCT1 (microbial community structure that has
a high correlation and positive loading with all pathogens)
Offenbacher
et al. [2]
TRA 0 rs3811273
TM9SF2P 1 rs9557237
GGTA2P 0 rs17184007
IFI16 1 rs1633266
RBMS3 0 rs17718700
C1QTNF7 0 rs4074082 Genome-wide significant association with PCT3 (high positive loading of GCF-IL-1β and
Aggregatibacter actinomycetemcomitans)
TSNARE 1 rs9772881
HPVC1 0 rs10232172 Genome-wide significant association with PCT4 (mixed-infection community with high
positive loading of GCF-IL1, weak positive loadings of Pn, Pi, and Td, and low levels of Aa)
SLC15A4 1 rs7135417 Genome-wide significant association with PCT5 (chronic periodontitis)
PKP2 2 rs6488099
SNRPN 9 rs904310
IL8 3 Regulation of innate and acquired immune response
Increased in gingival crevicular fluid from patients with periodontitis
Zhan et al.
[11]
CD44 34 Smoking-induced periodontal tissue destruction
CXCL1 7 Stimulation of lipopolysaccharide in oral fibroblasts which leads to development of
periodontal inflammation
IL6ST 17 Signal transducer for the interleukin family; regulates osteoclasts and calcium
homeostasis
CCR1 11 Trigger of bone resorption process
MMP7 7 Innate host defense in periodontal tissues
MMP13 10 Immunoreactivity in gingival crevicular fluid
MMP3 12 Physiological tissue remodeling of periodontal tissue
TLR9 0 Protective role against alveolar bone loss in the absence of Porphyromonas gingivalis
IL18 15 Inflammation and modulation of the activity of macrophages and neutrophils.
Significantly higher in patients with chronic periodontitis compared to healthy controls
IFNB1 0 TNFa, via the autocrine action of IFNbeta, differentially regulates the expression of
proinflammatory genes and DNA synthesis
GLT6D1 2 rs1537415 Genome-wide significant association with aggressive periodontitis Schaefer et
al. [12]
IL1B 8 The carriage rate of the R allele (frequency of N/R and R/R genotypes) among cases and
controls
Laine et al.
[13]
IL1RN 13
IL6 14
IL10 7
VDR 23
CD14 29
TLR4 4
MMP1 11
aGene names in bold were not used in the analysis because they were not well represented on the Infinium HumanMethylation450k array
bNumber of probes annotated to map to each gene in Infinium HumanMethylation450k array
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significant association with the presence of gingival bleed-
ing (beta = 2.17e−6, p value = 0.018; Fig. 1c) in a model
adjusting for age, smoking status, family structure, and
technical covariates. Subjects who experienced gingival
bleeding had lower levels of DNA methylation in the 5′
UTR of this gene and higher levels of exon expression
compared to controls, suggesting negative epigenetic
regulatory effects of cg21245277 on exon expression
(correlation = − 0.15, p value = 0.11).
To further explore the functional relevance of the most
associated gingival bleeding DNA methylation signal in
ZNF804A, we correlated the methylation levels at the most
associated CpG site in this gene (cg21245277) with 271
known fasting blood metabolites profiled by mass spec-
trometry [21]. Eight metabolites were found to be nomin-
ally associated with ZNF804A cg21245277 blood DNA
methylation levels (Fig. 1d). The strongest signal was
observed for ornithine (p value = 0.008), which is also sig-
nificantly associated with tooth mobility (p value = 0.012).
The remaining associated metabolites also included
3-dehydrocarnitine, ranked fifth (p value = 0.029), which is
consumed by gram-negative and gram-positive bacteria in
either aerobic or anaerobic environmental insults or as a
sole carbon, nitrogen, and energy source [26].
Epigenome-wide analyses of self-reported periodontitis
Epigenome-wide analyses of self-reported periodontitis
(tooth mobility) identified 58 epigenome-wide significant
CpG sites (Fig. 2a), although the results showed evidence for
moderate genomic inflation (lambda = 1.27). The two most
associated CpG sites (Table 3) were located in the gene body
of the IQCE gene (cg08157914; beta = 0.38, p value = 6.85e
−8, FDR < 0.001, Additional file 2: Table S2) and in the gene
body of the XKR6 gene (cg11051055; beta = − 0.49, p value
= 1.53e−8, FDR= 0.003, Additional file 3: Table S3).
Three (cg18353661, cg23681110, cg08453750) out of
58 CpG sites were located in or near to the genes that
also showed exon expression levels with a nominally sig-
nificant association with tooth mobility (Fig. 2b).
Twin-based heritability estimates decomposing the im-
pact of genetic, shared environmental, and unique envir-
onmental effects on the variance of each blood DNA
methylation level showed few strongly heritable sites
(heritability > 20% at 12 CpG sites), while the majority of
signals were explained by environmental contributions
(Fig. 2b). Interestingly, a common environmental com-
ponent was identified at 12 out of the 58 CpG sites.
We explored if the inclusion of technical and biological co-
variates could attenuate the genomic inflation observed in
the EWAS of tooth mobility. When we re-analyzed the data
using additional participants, that is, including subjects who
had dental visits more than 5 years before and after the DNA
extraction time (n= 717), the genomic inflation factor was at-
tenuated (lambda = 1.14) and only one epigenome-wide sig-
nificant signal remained. This signal was the top-ranked CpG
site from the set of 58 CpG reported above at cg08157914 in
IQCE (beta = 0.35, p value = 1.02–8, FDR=0.007).
Enrichment of differential methylation at chronic
periodontitis GWAS loci and biological candidates across
tissues
We integrated our genome-wide differential methylation
profiles in periodontal disease with previously published
candidate regions for chronic periodontitis. Altogether, we
explored data at 28 regions (247 CpG sites) that were previ-
ously identified either through GWAS efforts or biological
studies into periodontal disease (Table 2). We observed evi-
dence for enrichment of epigenetic associations with both
periodontal traits in the blood epigenome-wide results
(Fig. 3a). In blood, 26 CpG sites (tooth mobility) and 15
CpG sites (gingival bleeding) were nominally significantly
associated with dental phenotypes. CpG sites that were
nominally significantly associated with both periodontal
traits mapped to eight genes (VDR, IL6ST, TMCO6, IL1RN,
CD44, IL1B,WHAMM, and CXCL1).
To assess the persistence of dental phenotype associa-
tions across tissues, we carried out additional epigenetic
analyses between both periodontal traits and two further
epigenetic datasets from buccal and adipose tissue. In
buccal tissue, a stronger phenotype association enrich-
ment was observed compared to that in blood (Fig. 3b),
and 51 (tooth mobility) and 38 (gingival bleeding) CpG
sites were nominally associated with the dental pheno-
types. CpG sites that were nominally significantly
Table 3 The most associated epigenome-wide significant signals for both periodontal traits
bpa Annotation Estimateb P value FDR Genec Reported traits
Gingival bleeding CHR2: 185463218 1st exon; 5′ UTR − 0.33 7.17e−8 0.03 ZNF804A
(Zinc Finger Protein 8)
Bipolar disorder
Schizophrenia
Memory loss
Tooth mobility CHR7:
2646478
Body 0.38 6.85e−8 2.5e−4 IQCE
(IQ Motif Containing E)
Longevity
Blood metabolite level
CHR8: 11058145 Body − 0.49 1.53e−8 2.8e−3 XKR6
(XK Related 6)
Asthma
Allergic rhinitis
aCoordinate based on hg19
bEstimate represents the coefficient generated from the epigenetic linear regression model
cGene name derived from UCSC
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associated with both periodontal traits mapped to 16
genes (IL1RN, IL1B, CD44, VDR, MMP13, MED24,
CCR1, TMCO6, MMP3, IL6ST, TLR4, IL6, IL10, CXCL1,
WHAMM, and SNORD124), which included all 8 genes
detected in blood. In summary, enrichment of dental
phenotype association p values was observed in the
blood and buccal epigenetic profiles, while in contrast,
no enrichment was observed in adipose tissue (Fig. 3c).
We further explored the eight genes at which nomin-
ally significant differential methylation was detected in
both blood and buccal tissue across both tooth mobility
and gingival bleeding phenotypes. First, we carried out
tests of association between the phenotype-associated
blood DNA methylation signals and gene expression
levels at these eight genes within the linear mixed effects
regression framework. We found Bonferroni significant
A B
C
D
Fig. 1 ZNF804A differentially methylated signal for gingival bleeding in whole blood. a Visualization of the peak blood epigenome-wide signal for
gingival bleeding (top), along with genomic annotation of the region (middle) and co-methylation patterns (bottom panel). b The association
between ZNF804A blood methylation at cg21245277 and gingival bleeding. The y axis shows uncorrected methylation levels. c The association
between the normalized expression levels at exon ENSG00000170396.6_185463093_185463797 in ZNF804A and gingival bleeding (p value =
0.018). d The association between ZNF804A blood methylation levels at cg21245277 and eight metabolites. The y-axis represents the coefficient of
the model, and the p value of the association is shown in each bar
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associations (p = 0.00625) between periodontal traits
and exon expression levels for exons in WHAMM
(exon ENSG00000156232.5_83499351_83499831: beta
(SE) = 2.42e−6 (7.83e−7); p value = 2.2e−3, exon
ENSG00000156232.5_83495140_83495248: beta (SE) =
2.68e−6 (9.13e−7); p value = 3.6e−3, exon
ENSG00000156232.5_83477973_83479087: beta (SE) =
2.73e−6 (9.36e−7); p value = 3.9e−3) and TMCO6 (exon
ENSG00000113119.8_140023365_140023551: beta (SE)
= − 0.37 (0.13); p value = 6.0e−3). Second, to further ex-
plore their functional contribution, we examined the
association between the methylation levels of the
phenotype-associated CpG sites in these two genes
(cg00115297 in WHAMM and cg00916199 in TMCO6)
and fasting blood metabolites profiles. Nominally sig-
nificant associations with methylation levels at these
CpGs were observed for 48 metabolites (Fig. 4), with
the most associated signals for lipid-related metabolites.
Six out of 23 identified metabolites in a nominally
significant association with WHAMM methylation were
related to phosphocholine metabolism and the other
three were sulfate metabolites. With respect to the as-
sociation with TMCO6 methylation, 8 out of 25 identi-
fied metabolites were related to carnitine.
Discussion
We present the first large-scale epigenome-wide study of
periodontitis. Our results identified differential methyla-
tion at specific CpG sites between periodontal trait posi-
tive and negative individuals, which suggests that
epigenetic changes may help explain the variation in the
susceptibility to chronic periodontitis. Our findings de-
tected hypo-methylation in the 5′ UTR of ZNF804A and
corresponding upregulation of gene expression in indi-
viduals who experience gingival bleeding. These data
suggest that ZNF804A should be considered as a candi-
date gene related to gingival inflammation. Blood meta-
bolomics profile analysis highlighted eight metabolites,
A
B
Fig. 2 Epigenome-wide association results on tooth mobility. a Epigenome-wide association results, where the green dotted line shows the
epigenome-wide significance threshold (8.00e−06). There are 58 epigenome-wide significant associations with tooth mobility, showing positive
(red) and negative (blue) correlation with tooth mobility. b The percentage of each genetic, shared environmental, and unique environmental
factor contribution to the variance in methylation levels at the 58 CpG sites. Pink (A, heritability), green (C, common environment), and blue (E,
unique environment) bars represent genetic, shared environmental, and unique environmental effects, respectively. Three CpGs denoted by
“asterisk” are located in or near to genes that also showed exon expression levels with a nominally significant association with tooth mobility
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AB
C
Fig. 3 Evidence of methylation-phenotype association at candidate regions for chronic periodontitis across three tissues. The histograms show
the strength of association between methylation levels in blood (a), buccal (b), and adipose (c) tissues at CpG sites mapping to 28 candidate
regions for periodontal traits
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including ornithine and carnitine, which were signifi-
cantly associated with the differential methylation signal
in ZNF804A. Ornithine was reported to play an import-
ant role on metabolic cross-feeding between Streptococ-
cus gordonii and Fusobacterium nucleatum [27]. S.
godonii is thought to express an arginine-ornithine
antiporter, which potentially could influence the inter-
bacterial communication with periodontal pathogens.
Kuboniwa’s group also reported that the level of
ornithine in saliva showed a decreasing trend after an
intervention of debridement [28]. Taken together, these
findings suggest a potential sequence of events in early
stage periodontal disease that may lead towards disease
progression, where in early stage periodontal disease—
where gingival inflammation is observed—hypomethyla-
tion of cg21245277 may upregulate the expression of
A
B
Fig. 4 Functional metabolomic characterization of WHAMM and TMCO6 methylation signals. Blood metabolites showed a nominally significant
association with blood methylation levels at cg00115297 proximal to WHAMM (a) and at cg00916199 proximal to TMCO6 (b). The y-axis shows
the coefficient of the association between methylation and metabolites level
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ZNF804A, which in turn could elevate the level of orni-
thine in blood.
In terms of more severe stages of periodontal disease,
where tooth mobility or self-reported history of gum dis-
ease is a more appropriate phenotype marker, we identified
58 CpG sites with epigenome-wide significant signals, al-
though the observed genomic inflation may result in an in-
crease in the number of false positive findings that we
report here [29]. The most strongly associated signal for
this phenotype was in the gene body of the IQCE gene and
was hyper-methylated in individuals who presented with
tooth mobility, the severe stage of periodontitis. However,
there was not a significant signal for differential gene ex-
pression in this gene. Gene expression patterns associated
with methylation levels at tooth mobility-associated signals
were obtained at three CpG sites (out of 58 CpG sites) and
in three genes (MAD1L1,TRAPPC9, and OSBPL5). Epigen-
etic regulation may impact gene expression levels at these
genes in severe cases of periodontal disease. According to
the heritability findings for the variance of blood DNA
methylation levels, 21% of the 58 CpG sites showed more
than 20% genetic influence, and similarly, 23% of the vari-
ance of the methylation level on the CpG site related to
ZNF804A gene was explained by a genetic component.
This finding is consistent with previous reports that DNA
methylation levels can be under genetic control [30].
The most striking findings in our study were generated
from a candidate gene approach. We identified eight genes
(VDR, IL6ST, TMCO6, IL1RN, CD44, IL1B, WHAMM, and
CXCL1) that displayed methylation associations with both
periodontal traits across blood and buccal tissues. Of these,
WHAMM and TMCO6 were identified as likely signals of
genomic regulation in periodontal disease, due to a signifi-
cant association between phenotype-associated methylation
and gene expression levels at these genes. Both findings
suggest that WHAMM and TMCO6 are strong candidates
to shed light on epigenetic modifications over the course of
periodontal disease. WHAMM encodes a protein which
regulates the membrane dynamics and functions at the
interface of microtubule and actin cytoskeletons. This gene
was previously identified as a candidate from two different
GWAS studies in chronic periodontitis [1, 31]. TMCO6 is
located near CD14, which is an important contributor to
periodontal inflammation as it encodes a protein which is
part of the innate immune system and also recognizes lipo-
polysaccharides (LPS) components of gram-negative bacter-
ial cell wall. Several case-control studies also found
increased serum concentration of CD14 among the patients
with periodontitis [32, 33].
Further analysis with blood metabolites showed that the
epigenetic modifications at both WHAMM and TMCO6
were related to lipid metabolite biological pathways. Lipid
metabolism has been well studied in microbial organisms
including in periodontal pathogenic bacteria such as
Porphyromonas gingivalis and Aggregatibacter actinomy-
cemcomitans [34–36]. Approximately 30% of the metabo-
lites associated with TMCO6 methylation were related to
carnitine metabolism, which can be utilized by both
Gram-negative and Gram-positive bacteria [37]. Three out
of 23 identified metabolites related to WHAMM methyla-
tion levels were sulfates. Sulfate is known as a crucial
biological marker to evaluate periodontal disease as it is
one of the chemical components of glycosaminoglycans
[38], which are generally elevated under inflammatory
condition.
Our study has a number of limitations. Firstly, we used
self-reported data to assess periodontal disease status.
This is likely to underestimate the presence of disease
compared to the observational data including periodon-
tal pocket depth, attachment loss, and bleeding on prob-
ing in person by dental professionals. Our previous
validation study of the self-reported data, which included
80 individuals, showed that self-reported history of gum
disease or tooth mobility had low sensitivity, 0.28, but a
very high specificity and positive predictive value of 1
[39]. This result suggests that there is a high degree of
certainty about the periodontitis phenotype in test sub-
jects when compared against a control group of un-
known periodontal phenotype, which arguably decreases
the power of the study to detect a true difference be-
tween groups, but makes a type I error unlikely. This is
consistent with previous studies of self-reported peri-
odontitis where questions assessing loose teeth and pro-
fessional diagnosis of gum disease are good predictors of
periodontitis compared to other questions, but again, as
with our study, with low sensitivity [40, 41]. For gingival
bleeding, there was sensitivity of 0.48 and specificity of
0.75, respectively. There is very little existing data that
demonstrate the reliability of self-reported gingival
bleeding, and thus, our results with the gingival bleeding
trait should be treated with caution, particularly when
considering the relatively poor specificity seen in our
own validation.
Another limitation of our periodontal information is the
time difference between DNA extraction time and dental
phenotype collection, and dental questionnaires which
capture the history of periodontal conditions rather than
current status. However, we excluded participants for
whom the time difference between DNA extraction and
dental questionnaires was over 5 years. We reasoned that
subjects are likely to suffer from the same periodontal
condition for roughly 5 years, because periodontal disease
encompasses the nature of chronic inflammation.
Another limitation is our ability to address tissue specifi-
city in disease-relevant tissues. Epigenetic changes are
tissue-specific, and patterns in blood may not be shared
across tissues. Tissues within oral cavity such as gingiva,
buccal mucosa, and saliva are considered preferable to
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examine the regulatory genomic effects in periodontal
disease due to their involvement or proximity to
disease-affected areas [42]. Epigenetic modifications in the
oral cavity are, to date, considered to take place mostly in
epithelial tissue [43], and buccal swabs of the oral cavity
typically contain the greatest amount of epithelial tissue
[44]. We attempted to address this point by exploring
methylation profiles in a modest sample of buccal tissue.
A further limitation was the lack of follow-up valid-
ation of the most associated signals in our study using a
different DNA methylation profiling technology. For
example, one of the peak signals in our results,
cg21245277 in ZNF804A, contains several genetic vari-
ants in the probe sequence. Although these are not com-
mon genetic variants, they may still impact probe
hybridization efficiency. It would therefore be valuable
to validate the observed DNA methylation levels at this
CpG site using a different technology, for example, bi-
sulfite pyrosequencing. Furthermore, although the study
subjects in our sample were representative of the general
UK population and were not selected for major diseases,
such as rheumatoid arthritis, the conclusions may not
extend to all populations.
Although all of these drawbacks need to be further
considered, our notable findings from the epigenome-wide
analysis and candidate gene approach identify novel gen-
omic regions in periodontitis and highlight candidate genes
for further research. Previous studies examining epigen-
etic variation related to periodontitis have applied the
case-control design with moderate samples and limited
information on specific factors that may influence on
DNA methylation such as age, gender, smoking status,
and technical covariates. Overall, the current study sug-
gests that epigenetic modifications may play an import-
ant role in the susceptibility and progression of
periodontal disease. Future studies could focus on iden-
tifying environmental factors, which trigger DNA
methylation changes relevant to periodontitis. For ex-
ample, periodontal pathogenic bacteria could have the
potential to cause alteration in host cellular DNA
methylation status. Moreover, environmental factors
such as aging, smoking, and stress can have impacts on
epigenetic modifications. Further future work could ex-
plore in more depth the tissue specificity of epigenetic
modifications in periodontitis. Tissue-shared epigenetic
modifications are valuable as blood methylation data
are available in other cohorts, which allow us to
conduct replication studies. In the longer term, it may
be feasible to use DNA methylation profiles towards
personalized treatment and prevention of disease. For
example, DNA methylation levels at the most associ-
ated signals in our study may be used to identify sub-
jects at high risk of disease, towards modifications in
exposures for specific environmental risk factors.
Conclusions
Epigenome-wide analyses and a candidate gene approach
in adult female twins identified differentially methylated
signals in periodontal disease. In conjunction with tran-
scriptomics and metabolomics analyses, we conclude
that the epigenetic changes may have functional regula-
tory effects over the course of development and progres-
sion of periodontal disease.
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